| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10919573 | Radiotherapy and Oncology | 2013 | 7 Pages | 
Abstract
												Among the ELIOT population, the GEC-ESTRO recommendations enabled the selection of the good candidates with a low rate of local recurrence, but failed to differentiate the “possible candidates” and the “contraindication” groups.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Maria Cristina Leonardi, Patrick Maisonneuve, Mauro Giuseppe Mastropasqua, Anna Morra, Roberta Lazzari, Veronica Dell'Acqua, Annamaria Ferrari, Nicole Rotmensz, Claudia Sangalli, Alberto Luini, Umberto Veronesi, Roberto Orecchia, 
											